Endothelins increase tyrosine phosphorylation of astrocytic focal adhesion kinase and paxillin accompanied by their association with cytoskeletal components
Y Koyama , Y Yoshioka , H Hashimoto , T Matsuda , A Baba
{"title":"Endothelins increase tyrosine phosphorylation of astrocytic focal adhesion kinase and paxillin accompanied by their association with cytoskeletal components","authors":"Y Koyama , Y Yoshioka , H Hashimoto , T Matsuda , A Baba","doi":"10.1016/S0306-4522(00)00330-4","DOIUrl":null,"url":null,"abstract":"<div><p><span>Astrocytic endothelin receptors are involved in the appearance of activated astrocytes upon injury of the brain [Ishikawa N. </span><em>et al</em>. (1997) <em>Eur. J. Neurosci</em>. <strong>9,</strong> 895–901; Koyama Y. <em>et al</em>. (1999) <em>Glia</em> <strong>26,</strong><span><span> 268–271]. To clarify signal transduction triggered by endothelin receptors, we examined the effects of endothelins<span> on protein </span></span>tyrosine phosphorylation in cultured rat astrocytes. Endothelin-1 (1</span> <span>nM) increased tyrosine phosphorylation of focal adhesion kinase<span> and paxillin. The tyrosine phosphorylation was also induced by endothelin-1 (1</span></span> <!-->nM) and Ala<sup>1,3,11,15</sup>-endothelin-1 (10<!--> <!-->nM), an endothelin-B receptor agonist. BQ788 (100<!--> <span>nM), an endothelin-B receptor antagonist, inhibited the effects of endothelin-3. Orthovanadate (VO</span><sub>4</sub><sup>3−</sup><span><span>), a tyrosine phosphatase inhibitor, but not </span>bradykinin (1</span> <span>μM), angiotensin II (100</span> <span>nM), A23187 (5</span> <span>μM) and phorbol 12-myristate 13-acetate (100</span> <span>nM), increased tyrosine phosphorylation of focal adhesion kinase and paxillin. The tyrosine phosphorylation by endothelin-3 was not prevented by pertussis toxin, Ca</span><sup>2+</sup><span><span> chelation, protein kinase C inhibitors (calphostin C and staurosporine) or </span>wortmannin. Immunocytochemical staining showed that endothelin-3 and VO</span><sub>4</sub><sup>3−</sup><span> induced redistribution of focal adhesion kinase and paxillin to focal adhesions concomitant with stress fiber formation in dibutyryl cyclic-AMP-treated astrocytes. Treatment with endothelin-3 and VO</span><sub>4</sub><sup>3−</sup> increased focal adhesion kinase and paxillin associated with astrocytic cytoskeletal fraction. In the presence of cytochalasin B, an actin disrupting agent, endothelin-3 and VO<sub>4</sub><sup>3−</sup> did not phosphorylate focal adhesion kinase and paxillin. Application of cytochalasin B after treatment with endothelin-3 and VO<sub>4</sub><sup>3−</sup><span> stimulated dephosphorylation of focal adhesion kinase and paxillin.</span></p><p>These results suggest that the associations of focal adhesion kinase and paxillin with cytoskeletal components are required in the endothelin-induced tyrosine phosphorylation of the astrocytic proteins.</p></div>","PeriodicalId":19142,"journal":{"name":"Neuroscience","volume":"101 1","pages":"Pages 219-227"},"PeriodicalIF":2.9000,"publicationDate":"2000-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0306-4522(00)00330-4","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0306452200003304","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 26
Abstract
Astrocytic endothelin receptors are involved in the appearance of activated astrocytes upon injury of the brain [Ishikawa N. et al. (1997) Eur. J. Neurosci. 9, 895–901; Koyama Y. et al. (1999) Glia26, 268–271]. To clarify signal transduction triggered by endothelin receptors, we examined the effects of endothelins on protein tyrosine phosphorylation in cultured rat astrocytes. Endothelin-1 (1nM) increased tyrosine phosphorylation of focal adhesion kinase and paxillin. The tyrosine phosphorylation was also induced by endothelin-1 (1 nM) and Ala1,3,11,15-endothelin-1 (10 nM), an endothelin-B receptor agonist. BQ788 (100 nM), an endothelin-B receptor antagonist, inhibited the effects of endothelin-3. Orthovanadate (VO43−), a tyrosine phosphatase inhibitor, but not bradykinin (1μM), angiotensin II (100nM), A23187 (5μM) and phorbol 12-myristate 13-acetate (100nM), increased tyrosine phosphorylation of focal adhesion kinase and paxillin. The tyrosine phosphorylation by endothelin-3 was not prevented by pertussis toxin, Ca2+ chelation, protein kinase C inhibitors (calphostin C and staurosporine) or wortmannin. Immunocytochemical staining showed that endothelin-3 and VO43− induced redistribution of focal adhesion kinase and paxillin to focal adhesions concomitant with stress fiber formation in dibutyryl cyclic-AMP-treated astrocytes. Treatment with endothelin-3 and VO43− increased focal adhesion kinase and paxillin associated with astrocytic cytoskeletal fraction. In the presence of cytochalasin B, an actin disrupting agent, endothelin-3 and VO43− did not phosphorylate focal adhesion kinase and paxillin. Application of cytochalasin B after treatment with endothelin-3 and VO43− stimulated dephosphorylation of focal adhesion kinase and paxillin.
These results suggest that the associations of focal adhesion kinase and paxillin with cytoskeletal components are required in the endothelin-induced tyrosine phosphorylation of the astrocytic proteins.
期刊介绍:
Neuroscience publishes papers describing the results of original research on any aspect of the scientific study of the nervous system. Any paper, however short, will be considered for publication provided that it reports significant, new and carefully confirmed findings with full experimental details.